Ubiquitin–proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells

被引:0
|
作者
Ceshi Chen
Xiaodong Sun
Qimei Ran
Keith D Wilkinson
T J Murphy
Jonathan W Simons
Jin-Tang Dong
机构
[1] Winship Cancer Institute,Department of Oncology and Hematology
[2] Emory University School of Medicine,Department of Biochemistry
[3] Emory University School of Medicine,Department of Pharmacology
[4] Emory University School of Medicine,Department of Urology and Program in Genetics and Molecular Biology
[5] Emory University School of Medicine,undefined
来源
Oncogene | 2005年 / 24卷
关键词
KLF5; degradation; ubiquitin; proteasome; cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Ubiquitin-mediated proteolysis plays a central role in controlling intracellular levels of essential regulatory molecules such as p53, cyclins, myc, BRCA1, HIF-1α, etc. The Kruppel-like factor 5 (KLF5) transcription factor regulates biological processes involved in carcinogenesis, angiogenesis, and smooth muscle cell differentiation. In carcinogenesis, KLF5's role has been indicated by frequent genetic deletion as well as functional studies. Here we show that KLF5 is an unstable protein with a short half-life. Destruction of KLF5 was prevented by each of the proteasome-specific inhibitors tested but not by an inhibitor for trypsin-like proteases and cysteine proteases or by a lysosome inhibitor in epithelial cells. Furthermore, KLF5 underwent ubiquitination, and deletion of a 56-amino-acid sequence adjacent to a known transactivation domain of KLF5 significantly reduced its ubiquitination and degradation. Interestingly, cancer cells appeared to be more active in KLF5 degradation than untransformed epithelial cells, yet their proteasome activity was not higher. These results suggest that KLF5 protein is degraded at least in part through ubiquitination–proteasome pathway, which may have become hyperactive for KLF5 in cancer cells.
引用
收藏
页码:3319 / 3327
页数:8
相关论文
共 50 条
  • [31] Development of Low-Molecular-Weight Compounds Targeting the Cancer-Associated KLF5 Transcription Factor
    Nakaya, Takeo
    Aizawa, Kenichi
    Taguchi, Yuki
    Tsuji, Kentaro
    Sekine, Sachi
    Murakami, Kazuhiro
    Kasai, Masaji
    Nakano, Hirofumi
    Kondoh, Yasumitsu
    Dan, Shingo
    Yoshimori, Atsushi
    Kouji, Hiroyuki
    Takehara, Dai
    Suzuki, Toru
    Osada, Hiroyuki
    Murata, Masayuki
    Tanaka, Akira
    Nagai, Ryozo
    ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (04): : 687 - 694
  • [32] Kruppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation
    Oishi, Y
    Manabe, I
    Tobe, K
    Tsushima, K
    Shindo, T
    Fujiu, K
    Nishimura, G
    Maemura, K
    Yamauchi, T
    Kubota, N
    Suzuki, R
    Kitamura, T
    Akira, S
    Kadowaki, T
    Nagai, R
    CELL METABOLISM, 2005, 1 (01) : 27 - 39
  • [33] Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation
    Shi, Peiguo
    Zhou, Zhongmei
    Liu, Rong
    Chen, Ceshi
    CANCER RESEARCH, 2017, 77
  • [34] Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation
    Shi, Peiguo
    Liu, Wenjing
    Tala
    Wang, Haixia
    Li, Fubing
    Zhang, Hailin
    Wu, Yingying
    Kong, Yanjie
    Zhou, Zhongmei
    Wang, Chunyan
    Chen, Wenlin
    Liu, Rong
    Chen, Ceshi
    CELL DISCOVERY, 2017, 3
  • [35] Metformin suppresses triple-negative breast cancer stem cells by targeting KLF5 for degradation
    Peiguo Shi
    Wenjing Liu
    Haixia Tala
    Fubing Wang
    Hailin Li
    Yingying Zhang
    Yanjie Wu
    Zhongmei Kong
    Chunyan Zhou
    Wenlin Wang
    Rong Chen
    Ceshi Liu
    Cell Discovery, 3
  • [36] Development of low-molecular-weight compounds targeting the cancer-associated KLF5 transcription factor
    Nakaya, Takeo
    Aizawa, Kenichi
    Taguchi, Yuki
    Tsuji, Kentaro
    Sekine, Sachi
    Murakami, Kazuhiro
    Kondoh, Yasumitsu
    Dan, Shingo
    Yoshimori, Atsushi
    Kouji, Hiroyuki
    Takehara, Dai
    Suzuki, Toru
    Osada, Hiroyuki
    Murata, Masayuki
    Tanaka, Akira
    Nagai, Ryozo
    CANCER SCIENCE, 2023, 114 : 254 - 254
  • [37] Potential role of Kruppel-like transcription factor5 (KLF5) in adipocyte differentiation
    Oishi, Y
    Manabe, I
    Ishihara, A
    Tsushima, K
    Fujiu, K
    Nishimura, G
    Nagai, R
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 219 - 220
  • [38] KLF4 and KLF5 regulate proliferation, apoptosis and invasion in Esophageal cancer cells
    Yang, YZ
    Goldstein, BG
    Chao, HH
    Katz, JP
    CANCER BIOLOGY & THERAPY, 2005, 4 (11) : 1216 - 1221
  • [39] KLF4 and KLF5 are regulators of proliferation, differentiation, and apoptosis in esophageal cancer cells
    Yang, YZ
    Goldstein, BG
    Chao, HH
    Katz, J
    GASTROENTEROLOGY, 2005, 128 (04) : A602 - A602
  • [40] The Induction of KLF5 Transcription Factor by Progesterone Contributes to Progesterone-Induced Breast Cancer Cell Proliferation and Dedifferentiation
    Liu, Rong
    Zhou, Zhongmei
    Zhao, Dong
    Chen, Ceshi
    MOLECULAR ENDOCRINOLOGY, 2011, 25 (07) : 1137 - 1144